Top 5 Biotech Angel Investors in New Zealand (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Marko Bogoievski
Angel
|
2 | New Zealand | Convertible Note | Veterinary, Health Care, Biotechnology | |
|
Melanie Vivian
Angel
|
1 | New Zealand | Seed | Biotechnology, Product Research | |
|
Paul Davidson
Angel
|
1 | Finland, New Zealand, United Kingdom | Seed, Series A, Series B | SaaS, FinTech, Privacy | $934k–$2.9M |
|
David Ross
Angel
|
1 | New Zealand | Seed | Biopharma, Biotechnology | |
|
Serge van Dam
Angel
|
1 | New Zealand | Seed, Pre-Seed | Biotechnology, Product Research | |
| Access all 7 angel investors in New Zealand Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Investor list
Marko retired as CEO of Morrison & Co in 2021 after 13 years of leading the business. He continues to provide guidance for investments in telecommunications and digital infrastructure. His 30 year career has been in the infrastructure and technology sectors in a variety of senior finance, operational and sales roles in the United States and NewZealand. Prior to joining Morrison & Co in 2008, Marko was CFO of Telecom NZ, responsible for corporate finance, M&A and group strategy. Marko is Chair of Vodafone New Zealand.
Show more...Investment focus
- Industry: Veterinary, Health Care, Biotechnology
- Stage:Convertible Note
- Geography: New Zealand
Investor stats
- Total investments: 3
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Pictor — PictorDx offers a flexible multiplex proteomics platform that delivers multiple biomarker insights simultaneously and cost-effectively for multiple sample types
Melanie Vivian is an Angel Investor.
Show more...Investment focus
- Industry: Biotechnology, Product Research
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
Paul Davidson joined private equity group, West Coast Capital in 2005 following a successful career in corporate law in the UK, the US and Commonwealth of Independent States. As an active partner in West Coast Capital as well as providing legal counsel, Paul focusses on deal sourcing and transacting.Since joining the group, Paul has successfulyled the acquisition and delisting from the LSE of the UK's largest garden centre business, Wyevale as well as a series of acquisitions and disposals.Prior to joining West Coast Capital headed the corporate team of UK lawyers, McGrigors.In late 1994 Paul was seconded to an oil and gas company called JKX whose focus was on the former Soviet Union, primarily in Ukraine, Georgia and the Russian Federation. JKX listed on the London Stock Exchange in mid 1995 and at that time Paul joined the company as its Legal Director on a full time basis. During his time as Legal Director, Paul gained wide commercial experience as the company concluded a number of transactions throughout the former Soviet Union.
Show more...Investment focus
- Industry: SaaS, FinTech, Privacy
- Stage:Seed, Series A, Series B
- Geography: Finland, New Zealand, United Kingdom
Investor stats
- Total investments: 5
- Round size: Seed $934k–$2.9M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
- TVSquared — With trusted, independent attribution and partnerships with DSPs, publishers, advertisers and MVPDs, TVSquared measures the effectiveness of TV advertising through an infinitely scalable platform for linear, addressable and OTT/CTV.
David Ross
Show more...Investment focus
- Industry: Biopharma, Biotechnology
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Helico — Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world.
Serge has a depth of experience in technology startups that is difficult to rival. As CMO of M-Com, Serge led the growth of M-Com from a four person mobile commerce development company to the world's most successful provider of mobile banking and payment solutions (in both licensed and SaaS categories). He has since held executive levelpositions and Directorships, including as Chair on four boards, of many successful B2B SaaS companies. He is also an avid investor.
Show more...Investment focus
- Industry: Biotechnology, Product Research
- Stage:Seed, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
- Huckleberry — Build your professional reputation with AI-powered 360 feedback from colleagues. Huckleberry helps people develop their career and businesses to develop their teams.
Biotech Angel investor funding in New Zealand at a glance
Stats across 5 deals from 7 investors.
Access all 7 angel investors in New Zealand Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Angel Investors in New Zealand investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 7 angel investors investing in New Zealand Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Sign up with Google
Sign up with LinkedIn
